CSL Limited (CSLLY) Shareholder/Analyst Call Transcript

Core Points - The meeting is the 2025 Annual General Meeting of CSL, emphasizing the company's commitment to starting on time [2] - A video presentation features a patient, Melissa, who has hereditary angioedema (HAE), highlighting the effectiveness of CSL's products in managing her condition [2] - CSL's annual report is available for further insights into the company's purpose and its impact on patients' lives [3]